A5036550676- Bariatric Surgery and Outcomes
- Body Contouring and Surgery
- Diet and metabolism studies
- Esophageal and GI Pathology
- Obesity and Health Practices
- Nutrition and Health in Aging
- Diabetes Treatment and Management
- Intestinal and Peritoneal Adhesions
- Gastroesophageal reflux and treatments
- Hernia repair and management
- Gastric Cancer Management and Outcomes
- Enhanced Recovery After Surgery
- Obstructive Sleep Apnea Research
- Minimally Invasive Surgical Techniques
- Cardiovascular Disease and Adiposity
- Pancreatitis Pathology and Treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Muscle metabolism and nutrition
- Gastrointestinal motility and disorders
- Pharmacology and Obesity Treatment
- Esophageal Cancer Research and Treatment
- Nutritional Studies and Diet
- Metabolism, Diabetes, and Cancer
- Mobile Health and mHealth Applications
- Vitamin D Research Studies
Bergman Clinics
2024-2025
Rijnstate Hospital
2013-2022
RELX Group (United States)
2018
RELX Group (Netherlands)
2018
Philadelphia University
2018
RELX Group (United Kingdom)
2018
Janssen (Belgium)
2015
Major updates to 1991 National Institutes of Health guidelines for bariatric surgery.
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity co-morbidities.MBS should be considered metabolic disease BMI 30-34.9 kg/m2.BMI thresholds adjusted in the Asian population such that >25 kg/m2 suggests clinical obesity, >27.5 offered MBS.Long-term results MBS consistently demonstrate safety...
Recently, the laparoscopic sleeve gastrectomy (LSG) has become popular as a single-stage procedure for treatment of morbid obesity and its co-morbidities. However, incidence micronutrient deficiencies after LSG have hardly been researched.From January 2005 to October 2008, 60 patients underwent LSG. All were instructed take daily vitamin supplements. Patients tested 6 12 months surgery.Anemia was diagnosed in 14 (26%) patients. Iron, folic acid, B12 deficiency found 23 (43%), eight (15%),...
Thirty-five morbidly obese patients underwent Roux-en-Y gastric bypass surgery (RYGB). In addition to weight loss, these showed significant improvement of insulin resistance and a reduction hepatic fat content. Three months after surgery, the serum bile salts were slightly but significantly elevated, levels endocrine-acting fibroblast growth factor 19 (FGF19) FGF21 increased. FGF19 play role as regulators lipid glucose metabolism. These results show that RYGB improves metabolism this is...
Sleeve gastrectomy (SG) has become the most performed bariatric procedure to induce weight loss worldwide. Unfortunately, a significant portion of patients show insufficient or regain after few years.
Abstract Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, progressive disease. Recently, American Society of Bariatric Surgery (ASMBS) International Federation Obesity Disorders (IFSO) issued new guidelines on indications MBS, which have superseded previous 1991 National Institutes Health guidelines. The aim this study to establish first set consensus selecting procedures in Class I II using an Expert Modified...
Roux-en-Y gastric bypass (RYGB) and restrictive weight loss interventions, such as banding (GB) very-low-calorie diets (VLCD) directly impact glucose metabolism, possibly by calorie restriction and/or altered secretion of gut hormones. We aimed to establish the direct endocrine metabolic effects RYGB compared interventions in obese glucose-tolerant (NGT) subjects with type 2 diabetes (T2DM).Controlled, nonrandomized observational trial.Four groups females received a mixed meal at baseline 3...
Current guidelines recommend to avoid pregnancy for 12-24 months after bariatric surgery because of active weight loss and an increased risk nutritional deficiencies. However, high-quality evidence is lacking, only a few studies included data on gestational gain. We therefore evaluated neonatal outcomes by both surgery-to-conception interval gain.A multicenter retrospective analysis 196 singleton pregnancies following Roux-en-Y gastric bypass, sleeve gastrectomy, one anastomosis bypass was...
Severe vitamin D deficiency is a common finding in morbid obesity, and the incidence increases markedly after RYGB. Normalization of levels RYGB difficult to achieve because degree surgery-induced malabsorption not known.To develop test that quantifies changes intestinal cholecalciferol absorption induced by Roux-en-Y gastric bypass (RYGB) surgery.Absorption characteristics were studied 14 morbidly obese, premenopausal women before 4 weeks laparoscopic Serum measured at baseline 1, 2, 3,...
Background . Anemia associated with deficiencies in iron, folic acid, and vitamin B12 are very common after Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery for morbid obesity. This study was conducted to evaluate the prevalence of anemia LRYGB. Patients Methods A total 377 obese patients were included our study. All underwent a Hematologic parameters obtained prior on standardized time intervals. Results present 21 (<mml:math...
Iron, vitamin B12, and folic acid deficiencies are among the most common occurring after laparoscopic Roux-en-Y gastric bypass (LRYGB). The present study evaluates effectiveness of a specially designed multivitamin supplement (WLS Forte, FitForMe, Rotterdam, Netherlands) specifically developed for LRYGB patients. A triple-blind, randomized, 12-month was conducted comparing WLS forte with standard (sMVS) containing approximately 100% recommended daily allowance (RDA) iron, acid. Forte...